Singh, Steven
Georgetown University · Veterans Health Administration · Washington DC VA Medical Center
9 papers on CoChatORCID 0009-0001-1633-8415
Most cited papers
- Verified
Amiodarone versus sotalol for atrial fibrillation
Singh, B. N., Singh, S. N., Reda, D. J., Tang, X. C., Lopez, B., Harris, C. L., Fletcher, R. D., Sharma, S. C., Atwood, J. E., Jacobson, A. K., et al. (2005) · New England Journal of Medicine
Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments
Cited by 749
- Verified
Efficacy and Safety of Oral Dofetilide in Converting to and Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation or Atrial Flutter: The Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study
Singh, S., Zoble, R. G., Yellen, L., Brodsky, M. A., Feld, G. K., Berk, M., & Billing, C. B. (2000) · Circulation
Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments
Cited by 433
- Verified
Exercise Capacity and Mortality in Black and White Men
Kokkinos, P., Myers, J., Kokkinos, J. P., Pittaras, A., Narayan, P., Manolis, A., Karasik, P., Greenberg, M., Papademetriou, V., & Singh, S. (2008) · Circulation
Cardiovascular and exercise physiologyPhysical Activity and Health
Cited by 412
- Verified
Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs’ Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure)
Bilchick, K. C., Fetics, B., Djoukeng, R., Gross Fisher, S., Fletcher, R. D., Singh, S. N., Nevo, E., & Berger, R. D. (2002) · The American Journal of Cardiology
Heart Rate Variability and Autonomic ControlCardiac electrophysiology and arrhythmias
Cited by 288
- Verified
Intravenous Dofetilide, a Class III Antiarrhythmic Agent, for the Termination of Sustained Atrial Fibrillation or Flutter
Falk, R. H., Pollak, A., Singh, S. N., & Friedrich, T. (1997) · Journal of the American College of Cardiology
Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments
Cited by 215
- Verified
Exercise capacity and mortality in hypertensive men with and without additional risk factors.
Kokkinos, P., Manolis, A., Pittaras, A., Doumas, M., Giannelou, A., Panagiotakos, D. B., Faselis, C., Narayan, P., Singh, S., & Myers, J. (2009) · Hypertension
Cardiovascular and exercise physiologyPhysical Activity and Health
Cited by 120
- Verified
Exercise capacity and blood pressure associations with left ventricular mass in prehypertensive individuals
Kokkinos, P., Pittaras, A., Narayan, P., Faselis, C., Singh, S., & Manolis, A. (2007) · Hypertension
Blood Pressure and Hypertension StudiesCardiovascular and exercise physiology
Cited by 111
- Verified
Digoxin discontinuation and outcomes in patients with heart failure with reduced ejection fraction
Malik, A., Masson, R., Singh, S., Wu, W.-C., Packer, M., Pitt, B., Waagstein, F., Morgan, C. J., Allman, R. M., Fonarow, G. C., et al. (2019) · Journal of the American College of Cardiology
Heart Failure Treatment and ManagementHeart rate and cardiovascular health
Cited by 55
- Verified
Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate
Lam, P. H., Gupta, N., Dooley, D. J., Singh, S., Deedwania, P., Zile, M. R., Bhatt, D. L., Morgan, C. J., Pitt, B., Fonarow, G. C., et al. (2018) · The American Journal of Medicine
Heart Failure Treatment and ManagementHeart rate and cardiovascular health
Cited by 36
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free